Nonviral targeted mRNA delivery: principles, progresses, and challenges
Abstract Messenger RNA (mRNA) therapeutics have garnered considerable attention due to their remarkable efficacy in the treatment of various diseases. The COVID‐19 mRNA vaccine and RSV mRNA vaccine have been approved on the market. Due to the inherent nuclease‐instability and negative charge of mRNA...
Saved in:
Main Authors: | Xi He, Guohong Li, Letao Huang, Haixing Shi, Sha Zhong, Siyu Zhao, Xiangyu Jiao, Jinxiu Xin, Xiaoling Yin, Shengbin Liu, Zhongshan He, Mengran Guo, Chunli Yang, Zhaohui Jin, Jun Guo, Xiangrong Song |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | MedComm |
Subjects: | |
Online Access: | https://doi.org/10.1002/mco2.70035 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current issues with antibody-conjugated lipid nanoparticles
by: Aayush
Published: (2025-02-01) -
CleanCap M6 inhibits decapping of exogenously delivered IVT mRNA
by: Zachary F. Mandell, et al.
Published: (2025-03-01) -
Local delivery of TGF-β1-mRNA decreases fibrosis in osteochondral defects
by: Gianluca Fontana, et al.
Published: (2025-03-01) -
Precise intracellular uptake and endosomal release of diverse functional mRNA payloads via glutathione-responsive nanogels
by: Rupali Dabas, et al.
Published: (2025-02-01) -
In vivo production of engineered ACE2 decoy protects lungs from SARS-CoV-2 infection
by: Yuta Suzuki, et al.
Published: (2025-03-01)